This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
In a bid to control the microbial quality of pharmaceutical products, the Indian Pharmacopoeia Commission (IPC) has come out with a draft amendment to microbial contamination in non-sterile products in Indian Pharmacopoeia (IP) 2022.
American Amber Pearson used to wash her hands until they bled, terrified by the idea of contamination from everyday items, a debilitating result of her obsessive compulsive disorder (OCD).
In the clinicalresearch space, GxP is a set of quality regulations and guidelines designed to establish the safety, efficacy, and integrity of pharmaceuticals, medical devices, and clinical trials. This blog explores key concepts, regulations, and the importance of GxP in delivering successful clinical trials.
Among the various regulatory bodies providing oversight on clinicalresearch, only the institutional biosafety committee (IBC) has a purview specific to research involving engineered genetic materials. The post Risk Assessment for use of Engineered Genetic Materials in ClinicalResearch appeared first on Advarra.
Fungal nail infections may also spread through contact with contaminated surfaces, such as public showers, pool decks, or locker room floors. Participate in a Clinical Trial on Toenail Fungus at Olympian ClinicalResearch. In addition, sharing a toenail clipper with someone who has an infection may put you at risk.
You worry about contamination and catching/spreading germs. At Olympian ClinicalResearch we understand just how seriously the symptoms of OCD can impact every aspect of patients’ lives, and our team is committed to helping OCD patients find ways to effectively manage their symptoms long term and improve their quality of life.
Biosamples and biomarkers are the core basis for much of the work done in the clinicalresearch industry and proficient Human Biosample Management (HBSM) is necessary to procure reliable biosamples. Muscle tissues, nerve tissues, cell lines, blood cells, stem cells, and more. Sample Backup. Let’s use the easiest example of a sample.
FDA stated that the firm failed to adequately test each shipment of glycerin for diethylene glycol (DEG) or ethylene glycol (EG) contamination, failed to adequately validate production and process controls, and failed to conduct a retrospective review to ensure materials previously used were suitable for their intended use. Shah, M.D.,
In October 2019, this move continued with the acquisition of Symphony ClinicalResearch, providing at-home patient care across the UK and into Eastern Europe. The patients who are scared to go into hospitals at the moment and risk contamination of coronavirus (or anything else) with their weakened immune systems.
In October 2019, this move continued with the acquisition of Symphony ClinicalResearch, providing at-home patient care across the UK and into Eastern Europe. The patients who are scared to go into hospitals at the moment and risk contamination of coronavirus (or anything else) with their weakened immune systems.
If the data collection includes a laboratory specimen, patients must be given sample-specific lab kits and clear instructions on their usage to avoid contamination. With centralized trials involving visits to clinics, reports of adverse events could be addressed in a clinical setting. Governmental Accountability Office (GAO).
“Liquid biopsies have demonstrated promising activity in multiple clinical settings, but the great enthusiasm and expectations around them can be harmful if not adequately managed,” said Dr. El Mustapha Bahassi, PhD, Director, Clinical Laboratory Sciences, at the global clinicalresearch organization (CRO) Medpace.
Below are some free webinars you can register for that have delved into the topic: Continuing ClinicalResearch Innovations After COVID-19. The Impact of COVID-19 on Early Clinical Development – What the New Landscape Will Look Like. Addressing the Rapidly Evolving Vaccine Development Landscape.
We organize all of the trending information in your field so you don't have to. Join 21,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content